Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • NuGEN
    Registered Vendor
    • Jun 2010
    • 22

    #1

    NuGEN Announces the 2012 Genomics Grant Challenge Award

    In support of cutting edge genomic research, NuGEN is accepting applications for an award of up to $10,000 of NuGEN® reagents for Next-Gen sequencing studies.

    Submit a 500 word non-confidential study proposal by August 15, 2012 incorporating any of NuGEN's sample preparation solutions for transcriptome sequencing, sequencing studies with challenging samples, or metagenomics.
    Winner will be announced on September 14th, 2012 and studies can commence immediately thereafter.

    Proposals will be reviewed by a committee consisting of the NuGEN Scientific Advisory Board and senior technical teams. Innovative proposals are encouraged as awards will be based on novel and sound experimental design.

    Please visit the NuGEN website for the application form:

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2



    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection of antimicrobial...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...